Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Analysis of Passive Safety Surveillance Data of Dengue Vaccine, Qdenga (TAK 003) at Private Vaccination Centers, During 2023 and 2024 Dengue Season in Buenos Aires, Argentina

NCT06898775 is registered in ClinicalTrials.gov with Fundación Vacunar as lead sponsor.

NCT NCT06898775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06898775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Analysis of Passive Safety Surveillance Data of Dengue Vaccine, Qdenga (TAK 003) at Private Vaccination Centers, During 2023 and 2024 Dengue Season in Buenos Aires, Argentina
Lead sponsor
Fundación Vacunar
Phase
Observational
Overall status
Completed
Start date
November 1, 2023
Completion date
May 1, 2025
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dengue vaccines